Silodosin, a new α <sub>1A</sub> ‐adrenoceptor‐selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo‐controlled, double‐blind study in Japanese men
2006257 citationsJournal Articlebronze Open Access
Field-Weighted Citation Impact: 11.00
Silodosin, a new α <sub>1A</sub> ‐adrenoceptor‐selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo‐controlled, double‐blind study in Japanese men | Researchclopedia